These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35699622)

  • 21. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
    Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
    Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Label-Free Multiphoton Endomicroscopy for Minimally Invasive In Vivo Imaging.
    Dilipkumar A; Al-Shemmary A; Kreiß L; Cvecek K; Carlé B; Knieling F; Gonzales Menezes J; Thoma OM; Schmidt M; Neurath MF; Waldner M; Friedrich O; Schürmann S
    Adv Sci (Weinh); 2019 Apr; 6(8):1801735. PubMed ID: 31016109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal healing progression after acute colitis in mice.
    Vidal-Lletjós S; Andriamihaja M; Blais A; Grauso M; Lepage P; Davila AM; Gaudichon C; Leclerc M; Blachier F; Lan A
    World J Gastroenterol; 2019 Jul; 25(27):3572-3589. PubMed ID: 31367158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT.
    Hindryckx P; Staelens S; Devisscher L; Deleye S; De Vos F; Delrue L; Peeters H; Laukens D; De Vos M
    Inflamm Bowel Dis; 2011 Oct; 17(10):2058-64. PubMed ID: 21910167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
    Cooper HS; Murthy SN; Shah RS; Sedergran DJ
    Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
    Rigoni A; Bongiovanni L; Burocchi A; Sangaletti S; Danelli L; Guarnotta C; Lewis A; Rizzo A; Silver AR; Tripodo C; Colombo MP
    Cancer Res; 2015 Sep; 75(18):3760-70. PubMed ID: 26206557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
    Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
    J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut-Brain Axis: Insights from Hippocampal Neurogenesis and Brain Tumor Development in a Mouse Model of Experimental Colitis Induced by Dextran Sodium Sulfate.
    Vitali R; Prioreschi C; Lorenzo Rebenaque L; Colantoni E; Giovannini D; Frusciante S; Diretto G; Marco-Jiménez F; Mancuso M; Casciati A; Pazzaglia S
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
    Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dextran sulfate sodium-induced acute colitis impairs dermal lymphatic function in mice.
    Agollah GD; Wu G; Peng HL; Kwon S
    World J Gastroenterol; 2015 Dec; 21(45):12767-77. PubMed ID: 26668501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-223 improves intestinal inflammation through inhibiting the IL-6/STAT3 signaling pathway in dextran sodium sulfate-induced experimental colitis.
    Zhang J; Wang C; Guo Z; Da B; Zhu W; Li Q
    Immun Inflamm Dis; 2021 Mar; 9(1):319-327. PubMed ID: 33332758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease.
    Martin-Rodriguez O; Gauthier T; Bonnefoy F; Couturier M; Daoui A; Chagué C; Valmary-Degano S; Gay C; Saas P; Perruche S
    Front Immunol; 2021; 12():754475. PubMed ID: 35003066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency.
    Egger B; Bajaj-Elliott M; MacDonald TT; Inglin R; Eysselein VE; Büchler MW
    Digestion; 2000; 62(4):240-8. PubMed ID: 11070407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.
    Darsigny M; St-Jean S; Boudreau F
    Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
    J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Therapeutic Efficacy of Tonsil-derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-induced Acute Murine Colitis Model.
    Song EM; Jung SA; Lee KE; Jang JY; Lee KH; Tae CH; Moon CM; Joo YH; Kim SE; Jung HK; Shim KN
    Korean J Gastroenterol; 2017 Feb; 69(2):119-128. PubMed ID: 28239080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis.
    Matsumoto H; Haga K; Ohno I; Hiraoka K; Kimura T; Hermann K; Kasahara N; Anton P; McGowan I
    BMC Gastroenterol; 2014 Apr; 14():68. PubMed ID: 24712338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic imaging advances in murine models of colitis.
    Brückner M; Lenz P; Mücke MM; Gohar F; Willeke P; Domagk D; Bettenworth D
    World J Gastroenterol; 2016 Jan; 22(3):996-1007. PubMed ID: 26811642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.